Company

Last deal

$16.M

Amount

Series A

Stage

27.06.2024

Date

all rounds

$16.M

Total amount

Holoclara is an immunotherapy company providing nematode derived molecules for autoimmune disorders.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Holoclara is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

location

Social url